Better Choice Company And 2 Other Stocks Under $3 Insiders Are Buying
Better Choice Company And 2 Other Stocks Under $3 Insiders Are Buying
Better Choice Company和其他两只低于3美元的股票内部人士正在买入
The Dow Jones index closed lower by more than 250 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
道琼斯指数周一收盘下跌超过250点。当内部人士购买或出售股票时，这表明他们对公司前景的信心或担忧。对细价股感兴趣的投资者和交易者可以将此视为他们整体投资或交易决策的一个因素。
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.
以下是近期一些值得注意的细价股内幕交易。欲了解更多，请查看 本辛加的内幕交易 平台。
Sharps Technology
夏普斯科技
- The Trade: Sharps Technology, Inc. (NASDAQ:STSS) CEO Robert Michael Hayes acquired a total of 10,200 shares an average price of $0.36. To acquire these shares, it cost around $3,646.
- What's Happening: Sharps Technology signed a LOI with Roncadelle Operations enabling the companies to cooperatively sell and distribute each other's productive.
- What Sharps Technology Does: Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa ultra-low waste smart safety syringes are designed to eliminate over two million potentially infectious and accidental needlestick injuries.
- 交易：夏普斯科技公司（纳斯达克股票代码：STSS）首席执行官罗伯特·迈克尔·海斯 共收购了 10,200 股股票 平均价格为0.36美元。收购这些股票的成本约为3,646美元。
- 发生了什么：夏普斯科技与Roncadelle Operations签署了意向书，使两家公司能够合作销售和分配彼此的产品。
- 夏普斯科技做什么：夏普斯科技公司是一家医疗器械公司。它提供注射器和其他安全产品。Sharps provensa 超低浪费智能安全注射器旨在消除超过 200 万种潜在的传染性和意外针刺伤害。
Better Choice Company
更好的选择公司
- The Trade: Better Choice Company Inc. (NYSE:BTTR) Director
- Michael Young acquired a total of 1.14 million shares at at an average price of $0.20. To acquire these shares, it cost around $102,578.
- What's Happening: Better Choice, during November, posted a narrower-than-expected third-quarter loss.
- What Better Choice Company Does: Better Choice Co Inc is a pet health and wellness portfolio company, offering consumers a wide variety of recognized premium pet products and hemp-derived CBD supplements.
- 贸易：Better Choice Company Inc.（纽约证券交易所代码：BTTR）董事
- 迈克尔·杨 共收购了114万股股票 平均价格为0.20美元。收购这些股票的成本约为102,578美元。
- 发生了什么：Better Choice在11月公布的第三季度亏损低于预期。
- Better Choice公司的所作所为：Better Choice Co Inc是一家宠物健康和保健投资组合公司，为消费者提供各种公认的优质宠物产品和大麻衍生的CBD补充剂。
Arcadia Biosciences
阿卡迪亚生物科学
- The Trade: Arcadia Biosciences, Inc. (NASDAQ:RKDA) CFO Thomas J. Schaefer acquired a total of 700 shares at an average price of $2.06. The insider spent around $1,442 to buy those shares.
- What's Happening: Arcadia Biosciences, during November, posted a narrower-than-expected quarterly loss.
- What Arcadia Biosciences Does: Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products.
- 交易：阿卡迪亚生物科学公司（纳斯达克股票代码：RKDA）首席财务官托马斯·舍费尔 共收购了700股股票 平均价格为2.06美元。知情人士花费了约1,442美元购买了这些股票。
- 发生了什么：Arcadia Biosciences在11月公布的季度亏损低于预期。
- 阿卡迪亚生物科学公司做什么：阿卡迪亚生物科学公司是创新的植物性食品和饮料产品的生产商和销售商。
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的上市前报道